Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-006392
Filing Date
2023-02-02
Accepted
2023-02-02 18:24:56
Documents
2
Period of Report
2023-02-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4277
2 POA DOCUMENT poa.txt EX-24 3012
  Complete submission text file 0001209191-23-006392.txt   8758
Mailing Address SCHRODINGER, INC. 120 WEST 45TH STREET, 17TH FLOOR NEW YORK NY 10036
Business Address
Farid Ramy (Reporting) CIK: 0001797707 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41608 | Film No.: 23582814

Mailing Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080 (628) 229-9277
Structure Therapeutics Inc. (Issuer) CIK: 0001888886 (see all company filings)

EIN.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations